Profile
ABVX VRTX REGN VRNA ARGX ALNY
Company Name Abivax S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $7.45B $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.07K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Marc de Garidel Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABVX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ABVX VRTX REGN VRNA ARGX ALNY
Last Close $113.62 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $113.68 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $5.24 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -0.05 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 2068.32 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABVX VRTX REGN VRNA ARGX ALNY
1 Month Return 22.53 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 62.29 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 1790.52 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 1436.44 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 1452.19 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1175.2 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -293.27 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ABVX VRTX REGN VRNA ARGX ALNY
Asset Growth -37.25 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 135.94 % 1.16 % - 26.81 %
Revenue Growth 133.54 % 0.99 % - 22.97 %
Revenue 3 Year 7050.56 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year 104155.36 % 73.64 % - 775.72 %
Revenue 10 Year 11236.53 % 285.02 % - 2487.4 %
EBIT Growth -29.17 % 9.09 % -131.37 % 24.59 %
Net Income Growth -19.29 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -1.78 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -11.16 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -410.21 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -35.81 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -54.06 % - -143.33 % -107.98 %
Operating 3 Year CFG 17.27 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -8.35 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -585.58 % -100 % 40.15 % 97.08 %
EPS Growth 18.37 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 18.37 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -85.86 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -61.63 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -57.82 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -82.41 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 67.74 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -54.29 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ABVX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -163.31 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 5077.65 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -2731.94 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 98 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.12 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -3306.18 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -138.75 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 0.41 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.01 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 278.97 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 5.03 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.16 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.17 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 96.11 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -2273.9 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -138.75 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -54.4 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -44.12 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -44.12 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ABVX VRTX REGN VRNA ARGX ALNY
Revenue $0.01B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0.01B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 100% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.17B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.18B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -2.8 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ABVX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.05B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.16B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.04B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.1B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.21B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ABVX VRTX REGN VRNA ARGX ALNY
Net Income $-0.18B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.15B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ACLX Arcellx, Inc. 68.5
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.57 172.55
BIB ProShares Ultra Nasdaq Biotechnology 0.380557 84.7191
AADR AdvisorShares Dorsey Wright ADR ETF 2.63 94.735
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 57.7405
GVIP Goldman Sachs Hedge Industry VIP ETF 2.22 157.21
TLTD FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.0102 101.19
BOUT Innovator IBD Breakout Opportunities ETF 2.56 40.18
SPEU SPDR Portfolio Europe ETF 0.001349 55.22
BMED BlackRock Future Health ETF 0.1 30.48
FRTY Alger Mid Cap 40 ETF 1.35 20.66
IBBQ Invesco Nasdaq Biotechnology ETF 0.545989 29.429
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.55 7.345
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.000001 25.03
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.55 8.7175
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.5471 52.57
PINK Simplify Health Care ETF 0.60775 35.87
ATFV Alger 35 ETF 2.66 33.52
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.55 8.684
DBXW.DE Xtrackers MSCI World Swap UCITS ETF 0.832967 120.295
XWEH.F Xtrackers MSCI World Swap UCITS ETF 0.832967 32.014
XWD1.F Xtrackers MSCI World Swap UCITS ETF 0.832967 16.5615
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.5471 62.41
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 351.85
XMWD.L Xtrackers MSCI World Swap UCITS ETF 0.832967 142.865
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 30665
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.55 6.3925
LU2263803533.SG Xtrackers MSCI World Swap UCITS 0.842973 22.77
XWEH.DE Xtrackers MSCI World Swap UCITS ETF 0.832967 48.3
XWD1.SG Xtrackers MSCI World Swap UCITS 0.832967 23.165
TNXT T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Innovation Leaders ETF 0.187606 23.6631
IALT iShares Systematic Alternatives Active ETF 0.04 26.0903
Unlock